PT - JOURNAL ARTICLE AU - Patel, Nilesh AU - Taki, Mohammed AU - Tunstell, Paul AU - Forsey, Paul AU - Forbes, Ben TI - Stability of dobutamine 500 mg in 50 ml syringes prepared using a Central Intravenous Additive Service AID - 10.1136/ejhpharm-2011-000027 DP - 2012 Feb 01 TA - European Journal of Hospital Pharmacy: Science and Practice PG - 52--56 VI - 19 IP - 1 4099 - http://ejhp.bmj.com/content/19/1/52.short 4100 - http://ejhp.bmj.com/content/19/1/52.full SO - Eur J Hosp Pharm2012 Feb 01; 19 AB - Objectives A pharmacy Central Intravenous Additives Service (CIVAS) provides ready to use injectable medicines. However, manipulation of a licensed injectable medicine may significantly alter the stability of drug(s) in the final product. The aim of this study was to develop a stability indicating assay for CIVAS produced dobutamine 500 mg in 50 ml dextrose 1% (w/v) prefilled syringes, and to allocate a suitable shelf life. Methods A stability indicating high performance liquid chromatography (HPLC) assay was established for dobutamine. The stability of dobutamine prefilled syringes was evaluated under storage conditions of 4°C (protected from light), room temperature (protected from light), room temperature (exposed to light) and 40°C (protected from light) at various time points (up to 42 days). Results An HPLC method employing a Hypersil column, mobile phase (pH=4.0) consisting of 82:12:6 (v/v/v) 0.05 M KH2PO4:acetonitrile:methanol plus 0.3% (v/v) triethylamine with UV detection at λ=280 nm was specific for dobutamine. Under different storage conditions only samples stored at 40°C showed greater than 5% degradation (5.08%) at 42 days and had the shortest T95% based on this criterion (44.6 days compared with 111.4 days for 4°C). Exposure to light also reduced dobutamine stability. Discolouration on storage was the limiting factor in shelf life allocation, even when dobutamine remained within 5% of the initial concentration. Conclusions A stability indicating HPLC assay for dobutamine was developed. The shelf life recommended for the CIVAS product was 42 days at 4°C and 35 days at room temperature when protected from light.